No DGDA approval for antibody testing kit: Gonoshasthaya Kendra says

Gonoshasthaya Kendra claims its antibody testing kit did not get permission from the Directorate General of Drug Administration.

Dr Muhibullah Khandakar, coordinator of the rapid dot blot test kit development project, shared the information in a press statement circulated tonight.

“It is sad that the DGDA did not accept the recommendations made by BSMMU and refused to grant us a licence,” he said.

The Daily Star could not reach DGDA officials for comments at this time.


Leave a Comment

Covid-19 Live Update
%d bloggers like this:
Enable Notifications.    Ok No thanks